Medistim ASA (OSL: MEDI)
170.50
+5.50 (3.33%)
Aug 30, 2024, 4:25 PM CET
Medistim ASA Revenue
Medistim ASA had revenue of 144.92M NOK in the quarter ending June 30, 2024, with 5.48% growth. This brings the company's revenue in the last twelve months to 533.17M, up 2.67% year-over-year. In the year 2023, Medistim ASA had annual revenue of 521.11M with 7.17% growth.
Revenue (ttm)
533.17M
Revenue Growth
+2.67%
P/S Ratio
5.85
Revenue / Employee
3.53M
Employees
151
Market Cap
3.12B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 521.11M | 34.85M | 7.17% |
Dec 31, 2022 | 486.26M | 68.45M | 16.38% |
Dec 31, 2021 | 417.82M | 61.61M | 17.30% |
Dec 31, 2020 | 356.21M | -707.00K | -0.20% |
Dec 31, 2019 | 356.91M | 33.90M | 10.50% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nordhealth AS | 471.77M |
Nykode Therapeutics AS | 69.44M |
Photocure ASA | 513.58M |
Carasent ASA | 254.01M |
ArcticZymes Technologies ASA | 117.80M |
Hofseth BioCare ASA | 230.08M |
Gentian Diagnostics ASA | 151.51M |
Navamedic ASA | 543.49M |